miR-4324 inhibits ovarian cancer progression by targeting FEN1

被引:0
|
作者
Haixia Wu
Youliang Yan
Jialin Yuan
Mengze Luo
Yingjian Wang
机构
[1] Pinghu Hospital,Department of Obstetrics and Gynecology
[2] Health Science Center,Department of Obstetrics and Gynecology
[3] Shenzhen University,undefined
[4] China-Japan Union Hospital of Jilin University,undefined
关键词
miR-4324; FEN1; Ovarian cancer; Proliferation; Migration; Apoptosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] MiR-195-5p Inhibits Malignant Progression of Cervical Cancer by Targeting YAP1
    Liu, Xiaomin
    Zhou, Yi
    Ning, Yu-e
    Gu, Hui
    Tong, Yuxin
    Wang, Ning
    [J]. ONCOTARGETS AND THERAPY, 2020, 13 : 931 - 944
  • [42] MiR-1224 Acts as a Prognostic Biomarker and Inhibits the Progression of Gastric Cancer by Targeting SATB1
    Han, Guo-Dong
    Sun, Yuan
    Hui, Hong-Xia
    Tao, Ming-Yue
    Liu, Yang-Qing
    Zhu, Jing
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [43] Association of functional FEN1 genetic variants and haplotypes and breast cancer risk
    Lv, Zheng
    Liu, Weilin
    Li, Dongmei
    Liu, Lisheng
    Wei, Jinyu
    Zhang, Jingfeng
    Ge, Yunxia
    Wang, Zhiqiong
    Chen, Hongwei
    Zhou, Changchun
    Yuan, Qipeng
    Zhou, Liqing
    Yang, Ming
    [J]. GENE, 2014, 538 (01) : 42 - 45
  • [44] miR-138-5p inhibits the malignant progression of prostate cancer by targeting FOXC1
    Zhang, Dapeng
    Liu, Xiaodong
    Zhang, Qingwei
    Chen, Xin
    [J]. CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [45] MiR-330-3p inhibits gastric cancer progression through targeting MSI1
    Guan, Aoran
    Wang, Hui
    Li, Xun
    Xie, Hui
    Wang, Ruotian
    Zhu, Yankun
    Li, Ruhong
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (11): : 4802 - 4811
  • [46] miR-138-5p inhibits the malignant progression of prostate cancer by targeting FOXC1
    Dapeng Zhang
    Xiaodong Liu
    Qingwei Zhang
    Xin Chen
    [J]. Cancer Cell International, 20
  • [47] Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer
    Zhao, Enfa
    Zhou, Changli
    Chen, Shimin
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (01)
  • [48] miR-449a inhibits colorectal cancer progression by targeting SATB2
    Sun, Xiaohua
    Liu, Sanhong
    Chen, Pengfei
    Fu, Da
    Hou, Yingyong
    Hu, Jin
    Liu, Zhi
    Jiang, Yuhang
    Cao, Xinwei
    Cheng, Chunyan
    Chen, Xi
    Tao, Yu
    Li, Cuifeng
    Hu, Yiming
    Liu, Zhanjie
    Zhan, Yu
    Mao, Jie
    Wang, Qi
    Ma, Yushui
    Cong, Xianling
    Sun, Ran
    Shi, Yufang
    Wang, Mingliang
    Zhang, Xiaoren
    [J]. ONCOTARGET, 2017, 8 (60) : 100975 - 100988
  • [49] MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A
    Yuan, Daozhang
    Zheng, Shunsheng
    Wang, Liyan
    Li, Jing
    Yang, Jianan
    Wang, Bin
    Chen, Xiong
    Zhang, Xiaobo
    [J]. ONCOTARGET, 2017, 8 (40) : 67663 - 67669
  • [50] miR-329 inhibits papillary thyroid cancer progression via direct targeting WNT1
    Wu, Liang
    Pei, Fulai
    Men, Xiaojuan
    Wang, Kai
    Ma, Deliang
    [J]. ONCOLOGY LETTERS, 2018, 16 (03) : 3561 - 3568